Nasdaq:US$18.72 (-0.96) | HKEX:HK$29.70 (-0.65) | AIM:£3.04 (-0.09)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 19 Apr 2023

AACR 2023: HMPL-453, a highly selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays potent activity in FGFR-altered tumor models